g. IPF and scleroderma), even so the pathophysiology of those styles, depending on immediate administration of drug to tissue, differs considerably from scientific bleomycin?induced lung fibrosis. Alternatively, systemic administration of a pro?fibrotic drug like bleomycin need to far more carefully mimic the inflammatory and fibrotic processes fou